Cryptic Disorder Out of Disorder: Encounter Between Conditionally Disordered CP12 and Glyceraldehyde-3-Phosphate Dehydrogenase
Overview
Molecular Biology
Authors
Affiliations
Among intrinsically disordered proteins, conditionally disordered proteins undergo dramatic structural disorder rearrangements upon environmental changes and/or post-translational modifications that directly modulate their function. Quantifying the dynamics of these fluctuating proteins is extremely challenging but paramount to understanding the regulation of their function. The chloroplast protein CP12 is a model of such proteins and acts as a redox switch by formation/disruption of its two disulfide bridges. It regulates the Calvin cycle by forming, in oxidized conditions, a supramolecular complex with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and then phosphoribulokinase. In this complex, both enzymes are inactive. The highly dynamic nature of CP12 has so far hindered structural characterization explaining its mode of action. Thanks to a synergistic combination of small-angle X-ray scattering, nuclear magnetic resonance and circular dichroism that drove the molecular modeling of structural ensembles, we deciphered the structural behavior of Chlamydomonas reinhardtii oxidized CP12 alone and in the presence of GAPDH. Contrary to sequence-based structural predictions, the N-terminal region is unstable, oscillates at the ms timescale between helical and random conformations, and is connected through a disordered linker to its C-terminus, which forms a stable helical turn. Upon binding to GAPDH, oxidized CP12 undergoes an induced unfolding of its N-terminus. This phenomenon called cryptic disorder contributes to decrease the entropy cost and explains CP12 unusual high affinity for its partners.
NTRC regulates CP12 to activate Calvin-Benson cycle during cold acclimation.
Teh J, Leitz V, Holzer V, Neusius D, Marino G, Meitzel T Proc Natl Acad Sci U S A. 2023; 120(33):e2306338120.
PMID: 37549282 PMC: 10433458. DOI: 10.1073/pnas.2306338120.
Del Giudice A, Gurrieri L, Galantini L, Fanti S, Trost P, Sparla F Int J Mol Sci. 2023; 24(11).
PMID: 37298260 PMC: 10253348. DOI: 10.3390/ijms24119308.
Gerard C, Carriere F, Receveur-Brechot V, Launay H, Gontero B Biomolecules. 2022; 12(8).
PMID: 36008940 PMC: 9406205. DOI: 10.3390/biom12081047.
Reduction in Phosphoribulokinase Amount and Re-Routing Metabolism in CP12 Mutants.
Gerard C, Lebrun R, Lemesle E, Avilan L, Chang K, Jin E Int J Mol Sci. 2022; 23(5).
PMID: 35269851 PMC: 8910624. DOI: 10.3390/ijms23052710.
Launay H, Shao H, Bornet O, Cantrelle F, Lebrun R, Receveur-Brechot V Biomolecules. 2021; 11(5).
PMID: 34066751 PMC: 8151241. DOI: 10.3390/biom11050701.